$COLL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in COLLEGIUM PHARMACEUTICAL, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in COLLEGIUM PHARMACEUTICAL, INC. Get notifications about new insider transactions in COLLEGIUM PHARMACEUTICAL, INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 30 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Option Exercise | A | 14.57 | 9,414 | 137,162 | 9,414 | |
Apr 30 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 4,707 | 0 | 207,069 | 202.4 K to 207.1 K (+2.33 %) |
Apr 30 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 4,707 | 0 | 207,069 | 202.4 K to 207.1 K (+2.33 %) |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Fallon John A. | Director | Option Exercise | A | 14.57 | 9,414 | 137,162 | 9,414 | |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Fallon John A. | Director | Grant | A | 0.00 | 4,707 | 0 | 9,335 | 4.6 K to 9.3 K (+101.71 %) |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Option Exercise | A | 14.57 | 9,414 | 137,162 | 9,414 | |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Grant | A | 0.00 | 4,707 | 0 | 6,960 | 2.3 K to 7 K (+208.92 %) |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Option Exercise | A | 14.57 | 9,414 | 137,162 | 9,414 | |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Grant | A | 0.00 | 4,707 | 0 | 44,370 | 39.7 K to 44.4 K (+11.87 %) |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | A | 14.57 | 9,414 | 137,162 | 9,414 | |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Grant | A | 0.00 | 4,707 | 0 | 6,960 | 2.3 K to 7 K (+208.92 %) |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 14.57 | 9,414 | 137,162 | 9,414 | |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | SANTINI GINO | Director | Grant | A | 0.00 | 4,707 | 0 | 30,148 | 25.4 K to 30.1 K (+18.50 %) |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | BOHLIN GAREN G | Director | Option Exercise | A | 14.57 | 9,414 | 137,162 | 9,414 | |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | BOHLIN GAREN G | Director | Grant | A | 0.00 | 4,707 | 0 | 6,960 | 2.3 K to 7 K (+208.92 %) |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Option Exercise | A | 14.57 | 9,414 | 137,162 | 9,414 | |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Grant | A | 0.00 | 4,707 | 0 | 6,960 | 2.3 K to 7 K (+208.92 %) |
Apr 17 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 15.87 | 4,808 | 76,303 | 202,362 | 207.2 K to 202.4 K (-2.32 %) |
Apr 17 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 14.91 | 20,192 | 301,063 | 207,170 | 227.4 K to 207.2 K (-8.88 %) |
Apr 02 2019 | COLL | COLLEGIUM PHARMACE ... | Malamut Richard | EVP and Chief Medic ... | Option Exercise | A | 15.12 | 85,000 | 1,285,200 | 85,000 | |
Apr 02 2019 | COLL | COLLEGIUM PHARMACE ... | Malamut Richard | EVP and Chief Medic ... | Grant | A | 0.00 | 42,500 | 0 | 42,500 | 0 to 42.5 K |
Mar 19 2019 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Payment of Exercise | F | 16.98 | 1,470 | 24,961 | 44,130 | 45.6 K to 44.1 K (-3.22 %) |
Mar 19 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 17.17 | 25,000 | 429,250 | 227,362 | 252.4 K to 227.4 K (-9.91 %) |
Feb 20 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 15.06 | 7,068 | 106,444 | 252,362 | 259.4 K to 252.4 K (-2.72 %) |
Feb 20 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 14.71 | 17,932 | 263,780 | 259,430 | 277.4 K to 259.4 K (-6.47 %) |
Feb 11 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Payment of Exercise | F | 14.39 | 7,851 | 112,976 | 277,362 | 285.2 K to 277.4 K (-2.75 %) |
Feb 11 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Payment of Exercise | F | 14.39 | 2,052 | 29,528 | 196,606 | 198.7 K to 196.6 K (-1.03 %) |
Feb 11 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 14.39 | 2,693 | 38,752 | 152,288 | 155 K to 152.3 K (-1.74 %) |
Jan 29 2019 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Option Exercise | A | 15.90 | 25,600 | 407,040 | 25,600 | |
Jan 29 2019 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Grant | A | 0.00 | 25,600 | 0 | 41,786 | 16.2 K to 41.8 K (+158.16 %) |
Jan 29 2019 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | A | 15.90 | 25,600 | 407,040 | 25,600 | |
Jan 29 2019 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Grant | A | 0.00 | 25,600 | 0 | 77,968 | 52.4 K to 78 K (+48.88 %) |
Jan 29 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Option Exercise | A | 15.90 | 32,000 | 508,800 | 32,000 | |
Jan 29 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 0.00 | 32,000 | 0 | 154,981 | 123 K to 155 K (+26.02 %) |
Jan 29 2019 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Option Exercise | A | 15.90 | 25,600 | 407,040 | 25,600 | |
Jan 29 2019 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Grant | A | 0.00 | 25,600 | 0 | 45,600 | 20 K to 45.6 K (+128.00 %) |
Jan 29 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Option Exercise | A | 15.90 | 90,000 | 1,431,000 | 90,000 | |
Jan 29 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Grant | A | 0.00 | 90,000 | 0 | 198,658 | 108.7 K to 198.7 K (+82.83 %) |
Jan 23 2019 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Payment of Exercise | F | 15.76 | 214 | 3,373 | 52,368 | 52.6 K to 52.4 K (-0.41 %) |
Jan 23 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Payment of Exercise | F | 15.76 | 787 | 12,403 | 285,213 | 286 K to 285.2 K (-0.28 %) |
Jan 23 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 15.76 | 214 | 3,373 | 122,981 | 123.2 K to 123 K (-0.17 %) |
Jan 17 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 15.56 | 25,000 | 389,000 | 286,000 | 311 K to 286 K (-8.04 %) |
Dec 18 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 18.57 | 3,313 | 61,522 | 311,000 | 314.3 K to 311 K (-1.05 %) |
Dec 18 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 18.12 | 21,687 | 392,968 | 314,313 | 336 K to 314.3 K (-6.45 %) |
Dec 03 2018 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Payment of Exercise | F | 19.19 | 4,683 | 89,867 | 108,658 | 113.3 K to 108.7 K (-4.13 %) |
Nov 16 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 17.05 | 3,600 | 61,380 | 336,000 | 339.6 K to 336 K (-1.06 %) |
Nov 16 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 16.53 | 21,400 | 353,742 | 339,600 | 361 K to 339.6 K (-5.93 %) |
Nov 16 2018 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | J | 0.00 | 5,859 | 0 | 26,365 | 20.5 K to 26.4 K (+28.57 %) |
Nov 16 2018 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Sell | J | 0.00 | 400,000 | 0 | 1,149,916 | 1.5 M to 1.1 M (-25.81 %) |
Oct 17 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 16.53 | 25,000 | 413,250 | 361,000 | 386 K to 361 K (-6.48 %) |
Aug 27 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 18.03 | 599 | 10,800 | 123,195 | 123.8 K to 123.2 K (-0.48 %) |
Aug 27 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Payment of Exercise | F | 18.03 | 2,025 | 36,511 | 386,000 | 388 K to 386 K (-0.52 %) |
Aug 27 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Payment of Exercise | F | 18.03 | 599 | 10,800 | 52,582 | 53.2 K to 52.6 K (-1.13 %) |
Aug 06 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 20.15 | 181 | 3,647 | 123,794 | 124 K to 123.8 K (-0.15 %) |
Aug 06 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 15.84 | 539 | 8,538 | 123,975 | 123.4 K to 124 K (+0.44 %) |
Aug 06 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Payment of Exercise | F | 20.15 | 668 | 13,460 | 388,025 | 388.7 K to 388 K (-0.17 %) |
Aug 06 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Payment of Exercise | F | 20.15 | 181 | 3,647 | 53,181 | 53.4 K to 53.2 K (-0.34 %) |
Jul 12 2018 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Grant | A | 0.00 | 16,186 | 0 | 16,186 | 0 to 16.2 K |
Jul 02 2018 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Option Exercise | A | 23.85 | 41,418 | 987,819 | 41,418 | |
Jul 02 2018 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Grant | A | 0.00 | 25,140 | 0 | 113,341 | 88.2 K to 113.3 K (+28.50 %) |
Jun 22 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Sell | S | 28.35 | 4,900 | 138,915 | 123,436 | 128.3 K to 123.4 K (-3.82 %) |
Jun 22 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Sell | S | 27.50 | 5,100 | 140,250 | 128,336 | 133.4 K to 128.3 K (-3.82 %) |
Jun 13 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Sell | S | 27.00 | 4,096 | 110,592 | 53,362 | 57.5 K to 53.4 K (-7.13 %) |
Jun 13 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Sell | S | 25.26 | 53,057 | 1,340,220 | 388,693 | 441.8 K to 388.7 K (-12.01 %) |
Jun 13 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Sell | S | 25.28 | 96,943 | 2,450,719 | 441,750 | 538.7 K to 441.8 K (-18.00 %) |
Jun 04 2018 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | Chief Operating Off ... | Option Exercise | M | 8.22 | 64,821 | 532,829 | 194,462 | |
Jun 04 2018 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | Chief Operating Off ... | Sell | S | 22.48 | 14,862 | 334,098 | 88,201 | 103.1 K to 88.2 K (-14.42 %) |
Jun 04 2018 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | Chief Operating Off ... | Payment of Exercise | F | 22.62 | 6,205 | 140,357 | 103,063 | 109.3 K to 103.1 K (-5.68 %) |
Jun 04 2018 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | Chief Operating Off ... | Sell | S | 23.35 | 5,617 | 131,157 | 109,268 | 114.9 K to 109.3 K (-4.89 %) |
Jun 04 2018 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | Chief Operating Off ... | Sell | S | 22.54 | 59,204 | 1,334,458 | 114,885 | 174.1 K to 114.9 K (-34.01 %) |
Jun 04 2018 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | Chief Operating Off ... | Buy | M | 8.22 | 64,821 | 532,829 | 174,089 | 109.3 K to 174.1 K (+59.32 %) |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Fallon John A. | Director | Option Exercise | A | 24.95 | 4,506 | 112,425 | 4,506 | |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Fallon John A. | Director | Grant | A | 0.00 | 2,253 | 0 | 4,628 | 2.4 K to 4.6 K (+94.86 %) |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Option Exercise | A | 24.95 | 4,506 | 112,425 | 4,506 | |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Grant | A | 0.00 | 2,253 | 0 | 2,253 | 0 to 2.3 K |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Option Exercise | A | 24.95 | 4,506 | 112,425 | 4,506 | |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Grant | A | 0.00 | 2,253 | 0 | 2,253 | 0 to 2.3 K |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | BOHLIN GAREN G | Director | Option Exercise | A | 24.95 | 4,506 | 112,425 | 4,506 | |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | BOHLIN GAREN G | Director | Grant | A | 0.00 | 2,253 | 0 | 2,253 | 0 to 2.3 K |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | A | 24.95 | 4,506 | 112,425 | 4,506 | |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Grant | A | 0.00 | 2,253 | 0 | 2,253 | 0 to 2.3 K |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Option Exercise | A | 24.95 | 4,506 | 112,425 | 4,506 | |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Grant | A | 0.00 | 2,253 | 0 | 27,193 | 24.9 K to 27.2 K (+9.03 %) |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 24.95 | 4,506 | 112,425 | 4,506 | |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | SANTINI GINO | Director | Grant | A | 0.00 | 2,253 | 0 | 25,441 | 23.2 K to 25.4 K (+9.72 %) |
Apr 23 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Sell | S | 26.01 | 100 | 2,601 | 545,793 | 545.9 K to 545.8 K (-0.02 %) |
Apr 23 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Sell | S | 26.00 | 44,300 | 1,151,800 | 545,893 | 590.2 K to 545.9 K (-7.51 %) |
Apr 05 2018 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Option Exercise | A | 24.03 | 40,000 | 961,200 | 40,000 | |
Apr 05 2018 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Apr 04 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | M | 0.28 | 3,917 | 1,097 | 0 | |
Apr 04 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | M | 0.28 | 4,225 | 1,183 | 0 | |
Apr 04 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Buy | M | 0.28 | 3,917 | 1,097 | 57,458 | 53.5 K to 57.5 K (+7.32 %) |
Apr 04 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Buy | M | 0.28 | 4,225 | 1,183 | 53,541 | 49.3 K to 53.5 K (+8.57 %) |
Mar 21 2018 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | J | 0.00 | 8,791 | 0 | 20,506 | 11.7 K to 20.5 K (+75.04 %) |
Mar 21 2018 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Sell | J | 0.00 | 600,000 | 0 | 1,549,916 | 2.1 M to 1.5 M (-27.91 %) |
Mar 01 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Payment of Exercise | F | 21.77 | 4,050 | 88,169 | 590,193 | 594.2 K to 590.2 K (-0.68 %) |
Mar 01 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 21.77 | 1,197 | 26,059 | 133,436 | 134.6 K to 133.4 K (-0.89 %) |
Mar 01 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Payment of Exercise | F | 21.77 | 1,193 | 25,972 | 49,316 | 50.5 K to 49.3 K (-2.36 %) |
Feb 06 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 23.38 | 214 | 5,003 | 134,633 | 134.8 K to 134.6 K (-0.16 %) |
Feb 06 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Payment of Exercise | F | 23.38 | 214 | 5,003 | 50,509 | 50.7 K to 50.5 K (-0.42 %) |
Feb 06 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Payment of Exercise | F | 23.38 | 788 | 18,423 | 594,243 | 595 K to 594.2 K (-0.13 %) |
Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Option Exercise | A | 24.35 | 150,000 | 3,652,500 | 150,000 | |
Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Grant | A | 10.17 | 1,044 | 10,617 | 595,031 | 594 K to 595 K (+0.18 %) |
Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Grant | A | 0.00 | 75,000 | 0 | 593,987 | 519 K to 594 K (+14.45 %) |
Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | Chief Operating Off ... | Option Exercise | A | 24.35 | 50,000 | 1,217,500 | 50,000 | |
Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | Chief Operating Off ... | Grant | A | 0.00 | 25,000 | 0 | 109,268 | 84.3 K to 109.3 K (+29.67 %) |
Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Option Exercise | A | 24.35 | 50,000 | 1,217,500 | 50,000 | |
Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 10.17 | 1,044 | 10,617 | 134,847 | 133.8 K to 134.8 K (+0.78 %) |
Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 0.00 | 25,000 | 0 | 133,803 | 108.8 K to 133.8 K (+22.98 %) |
Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Gift | G | 0.00 | 2,000 | 0 | 108,803 | 110.8 K to 108.8 K (-1.81 %) |
Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | A | 24.35 | 50,000 | 1,217,500 | 50,000 | |
Jan 29 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Grant | A | 0.00 | 25,000 | 0 | 50,723 | 25.7 K to 50.7 K (+97.19 %) |
Jan 23 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Sell | S | 25.01 | 16,408 | 410,364 | 518,987 | 535.4 K to 519 K (-3.06 %) |
Jan 23 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Sell | S | 25.00 | 3,592 | 89,800 | 535,395 | 539 K to 535.4 K (-0.67 %) |
Jan 19 2018 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Sell | S | 22.50 | 20,000 | 450,000 | 538,987 | 559 K to 539 K (-3.58 %) |
Jan 12 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | M | 0.48 | 6,928 | 3,325 | 5,753 | |
Jan 12 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Sell | S | 19.07 | 6,928 | 132,117 | 25,723 | 32.7 K to 25.7 K (-21.22 %) |
Jan 12 2018 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Buy | M | 0.48 | 6,928 | 3,325 | 32,651 | 25.7 K to 32.7 K (+26.93 %) |
Dec 12 2017 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Sell | S | 17.34 | 19,650 | 340,731 | 45,620 | 65.3 K to 45.6 K (-30.11 %) |
Dec 12 2017 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Sell | S | 17.34 | 980,350 | 16,999,269 | 2,276,222 | 3.3 M to 2.3 M (-30.10 %) |
Dec 12 2017 | COLL | COLLEGIUM PHARMACE ... | Longitude Capital Partners, LL ... | 10% Owner | Sell | S | 17.34 | 19,650 | 340,731 | 45,620 | 65.3 K to 45.6 K (-30.11 %) |
Dec 12 2017 | COLL | COLLEGIUM PHARMACE ... | Longitude Capital Partners, LL ... | 10% Owner | Sell | S | 17.34 | 980,350 | 16,999,269 | 2,276,222 | 3.3 M to 2.3 M (-30.10 %) |
Dec 07 2017 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | J | 0.00 | 11,715 | 0 | 11,715 | 0 to 11.7 K |
Dec 07 2017 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Sell | J | 0.00 | 800,000 | 0 | 2,149,916 | 2.9 M to 2.1 M (-27.12 %) |
Dec 07 2017 | COLL | COLLEGIUM PHARMACE ... | KANEKO YASUNORI | 10% Owner | Buy | J | 0.00 | 270 | 0 | 270 | 0 to 270 |
Dec 07 2017 | COLL | COLLEGIUM PHARMACE ... | KANEKO YASUNORI | 10% Owner | Sell | J | 0.00 | 800,000 | 0 | 2,149,916 | 2.9 M to 2.1 M (-27.12 %) |
Dec 07 2017 | COLL | COLLEGIUM PHARMACE ... | Skyline Venture Partners V LP | 10% Owner | Sell | J | 0.00 | 800,000 | 0 | 2,149,916 | 2.9 M to 2.1 M (-27.12 %) |
Nov 21 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | M | 0.28 | 572 | 160 | 3,917 | |
Nov 21 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | M | 0.28 | 1,239 | 347 | 4,489 | |
Nov 21 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | M | 0.28 | 1,950 | 546 | 4,225 | |
Nov 21 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Sell | S | 19.00 | 572 | 10,868 | 25,723 | 26.3 K to 25.7 K (-2.18 %) |
Nov 21 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Buy | M | 0.28 | 572 | 160 | 26,295 | 25.7 K to 26.3 K (+2.22 %) |
Nov 21 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Sell | S | 17.00 | 840 | 14,280 | 25,723 | 26.6 K to 25.7 K (-3.16 %) |
Nov 21 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Sell | S | 17.00 | 1,239 | 21,063 | 26,563 | 27.8 K to 26.6 K (-4.46 %) |
Nov 21 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Buy | M | 0.28 | 1,239 | 347 | 27,802 | 26.6 K to 27.8 K (+4.66 %) |
Nov 21 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Sell | S | 17.00 | 1,950 | 33,150 | 26,563 | 28.5 K to 26.6 K (-6.84 %) |
Nov 21 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Buy | M | 0.28 | 1,950 | 546 | 28,513 | 26.6 K to 28.5 K (+7.34 %) |
Nov 17 2017 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Sell | S | 15.53 | 50,000 | 776,500 | 558,987 | 609 K to 559 K (-8.21 %) |
Oct 27 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | M | 3.38 | 1,811 | 6,121 | 0 | |
Oct 27 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Buy | M | 3.38 | 1,811 | 6,121 | 26,563 | 24.8 K to 26.6 K (+7.32 %) |
Aug 11 2017 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Option Exercise | A | 9.89 | 25,067 | 247,913 | 25,067 | |
Aug 04 2017 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Payment of Exercise | F | 12.39 | 736 | 9,119 | 608,987 | 609.7 K to 609 K (-0.12 %) |
Aug 04 2017 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Chairman, President ... | Grant | A | 10.60 | 640 | 6,784 | 609,723 | 609.1 K to 609.7 K (+0.11 %) |
Aug 04 2017 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 12.39 | 200 | 2,478 | 110,803 | 111 K to 110.8 K (-0.18 %) |
Aug 04 2017 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 10.60 | 776 | 8,226 | 111,003 | 110.2 K to 111 K (+0.70 %) |
Aug 04 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Payment of Exercise | F | 12.39 | 200 | 2,478 | 24,752 | 25 K to 24.8 K (-0.80 %) |
Aug 04 2017 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Grant | A | 10.60 | 639 | 6,773 | 24,952 | 24.3 K to 25 K (+2.63 %) |
May 25 2017 | COLL | COLLEGIUM PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 9.33 | 19,853 | 185,228 | 19,853 | |
May 25 2017 | COLL | COLLEGIUM PHARMACE ... | BOHLIN GAREN G | Director | Option Exercise | A | 9.33 | 19,853 | 185,228 | 19,853 | |
May 25 2017 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Option Exercise | A | 9.33 | 19,853 | 185,228 | 19,853 |